http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017082655-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ed4670d918b357d2cfd726f024b4c24 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y401-03004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate | 2016-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b18964c4738538a444963ed43177eb4b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0bd522419d8f9ed0eeb324d4f66482f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5dca857ab37be165ea32922ae65e90b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d242d397f3f1c0b9ec531c0eb0b151f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f248f85ee1cc8e09e6d2f761f6d86016 |
| publicationDate | 2017-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2017082655-A1 |
| titleOfInvention | Methods for determining resistance to anticancer therapy and composition used therefor |
| abstract | The present invention relates to a pharmaceutical composition for the prevention or treatment of malignant tumor comprising an agent for inhibiting the expression of HMGCLL1 IS3, a pharmaceutical composition for the prevention or treatment of malignant tumor showing resistance to tyrosine kinase inhibitor, a method for determining a drug resistance in an individual having malignant tumors using the expression level of HMGCLL1 IS3, a composition and a kit for diagnosing drug resistance used for said method, a method for determining the probability of developing malignant tumor using the expression level of HMGCLL1 IS3, a method for screening a malignant tumor therapeutic agent using the expression level of HMGCLL1 IS3, a method for predicting malignant tumor prognosis using the expression level of HMGCLL1 IS3, a composition and a kit for predicting the prognosis of malignant tumor including an agent capable of measuring the expression level of HMGCLL1 IS3, a method for determining drug resistance in an individual having malignant tumor using SNP, a composition and a kit for diagnosing drug resistance used for said method, a method for determining the probability of developing malignant tumor using SNP, a method for predicting malignant tumor prognosis using SNP, and a composition and a kit for predicting the prognosis of malignant tumor used for said method. The method of the present invention can effectively predict or diagnose drug tolerance of chronic myelogenous leukemia and malignant tumor patients, and can further be used for efficient drug therapy and drug development research. |
| priorityDate | 2015-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.